Dengue fever is a disease spread by mosquito's bite. Dengue fever is marked by the presence of thrombocytopenia. Traditional crops such as guava are commonly used to treat dengue fever. This research aims to know the effect of guava extract administration towards megakaryocytes amount in mice femur. The study was conducted at the Laboratory of Pharmacology and Therapy, Histology Laboratory of Faculty of Medicine at Universitas Padjadjaran, Eijkman, Bandung from September until November 2016 using laboratory experimental study design. 20 Swiss webster mice strains were divided randomly into 4 groups. Group I and II were administered quinine 2.8 mg/20 grBW/day for 14 days to decrease amount of trombocytes. Group II and III were administered guava extract 0.785 mg/20 grBW/day for 5 days. Group IV was administered aquadest for 19 days. In the 27 th day, the mice left femurs were collected and made into paraffin section preparations with hematoxylin-eosin staining and then observed under microscope. Group IV had the most megakaryocytes followed by Group II, III, and I. Based on Kruskal-Wallis test, a significant difference was shown (p<0.05). MannWhitney test showed that there were significant differences between Group I and Group II, III, and IV. Meanwhile there was no significant difference between normal mice and extract-given mice. Guava extract is proven statistically significant to increase the megakaryocytes amount in thrombocytopenic mice without increasing number of megakaryocytes in normal mice.
Objective: The objective of this study was to evaluate the beneficial effect of topical applications of 20% sunflower seed oil (SSO) in decreasing the transepidermal water loss (TEWL) and scoring of atopic dermatitis (SCORAD) index value in mild atopic dermatitis (AD) pediatric patients in Bandung, Indonesia. Methods: This was a randomized study involving 20 children with mild AD (SCORAD<25) in Bandung, Indonesia. They were divided into 2 groups: the experimental group treated with 20% SSO cream and the control group treated with a common moisturizing cream for four weeks. The TEWL score including SCORAD index was evaluated at baseline, week 1, week 2, and week 4. Results: A total of 20 participants completed the study. In the first week, the control group had TEWL score decrement by 36.62% while the experimental group by 28.89% (p=0.88). In the fourth week, the TEWL decrements of the experimental and control group were by 56.94% and 52.50%, respectively (p=0.20), and this was followed by an improvement of SCORAD index in both treatment groups. Conclusion: The 20% SSO cream has a beneficial effect in decreasing the TEWL score and improving SCORAD indices. Therefore, it can be considered as an alternative treatment for mild AD among children.
Stevens-Johnson Syndrome is a mucocutaneous disease caused by allergic drug eruption. Antiretroviral (ARV) therapy for HIV/AIDS patient may cause allergic drug eruption such as Stevens-Johnson Syndrome.The aim of this research was to find out the prevalence of Stevens-Johnson Syndrome caused by ARV in hospitalize patient at Dr.Hasan Sadikin General Hospital Bandung from January to December 2008.It was a descriptive research by taking the secondary data from patient’s medical record. The result of this research showed that from 20 Stevens-Johnson Syndrome patients, 12 persons of them (60%) are men.Most of the patients were between the age of 20-29 (45%).Oral manifestation of Stevens-Johnson Syndrome seen in 100% patients.Prevalence of Stevens-Johnson Syndrome caused by ARV was 28.6% which seen in 8 HIV/AIDS patients.ARV combination consists of nevirapine, lamivudine, and zidovudine was the most (50.0%) ARV which suspected causing Stevens-Johnson Syndrome.The conclusion of this research showed that the prevalence of Stevens-Johnson Syndrome caused by ARV in hospitalize patient at Dr.Hasan Sadikin General Hospital Bandung 2008 was 28.6% seen in 8 HIV/AIDS patients.
Psoriasis disertai penyakit bulosa autoimun yang terjadi pada satu orang sangat jarang terjadi. Diduga terdapat peranan plasminogenactivator, predisposisi genetik, atau faktor pencetus infeksi dalam patogenesis psoriasis yang disertai pemfigus foliaseus. Metotreksat dilaporkan efektif sebagai terapi psoriasis pustulosa dan azatioprin sebagai terapi penyakit bulosa autoimun menimbulkan efek samping yang lebih dapat ditoleransi.Dilaporkan seorang pasien laki-laki berusia 38 tahun dengan diagnosis psoriasis pustulosa generalisata disertai pemfigus foliaseus. Selain gambaran klinis, diagnosis psoriasis pustulosa ditegakkan dengan pemeriksaan histopatologis, sedangkan diagnosis pemfigus foliaseus ditegakkan melalui pemeriksaan histopatologis dan direct immunofluorescence (DIF). Pasien diterapi dengan kombinasi metotreksat 3x5 mg/minggu dan azatioprin 2x100 mg/hari. Setelah dua minggu mendapat terapi kombinasi, terjadi perbaikan klinis dan tidak ditemukan lesi baru. Psoriasis dan penyakit bulosa autoimun pada satu orang sulit terapinya karena penggunaan dan penghentian kortikosteroid sistemik dapat mencetuskan psoriasis pustulosa. Pada pasien ini, dipilih metotreksat sebagai terapi psoriasis pustulosa generalisata karena efektivitasnya baik dan tersedia di Indonesia. Azatioprin diberikan untuk terapi pemfigus foliaseus atas pertimbangan efek samping yang jarang terjadi dibandingkan obat imunosupresan lainnya. Dilaporkan satu pasien usia 38 tahun dengan psoriasis pustulosa generalisata disertai pemfigus foliaseus yang mendapatkan terapi kombinasi metotreksat 3x5 mg/minggu dan azatioprin 2x100 mg/hari. Perbaikan klinis didapatkan setelah dua minggu pengobatan. Kata kunci: azatioprin, metotreksat, pemfigus foliaseus, psoriasis pustulosa generalisata
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.